Orchid Cellmark | GenomeWeb

Orchid Cellmark

MP Biomedicals has named Todd Nelson president and CEO, replacing Milan Panic, founder and CEO, who will remain as chairman of the company.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Laboratory Corporation of America today said that it has successfully completed its cash tender offer for all outstanding shares of Orchid Cellmark.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Laboratory Corporation of America again is extending its bid to acquire Orchid Cellmark.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Orchid Cellmark reported on Monday a 7 percent decline year over year in third-quarter revenues.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Laboratory Corporation of America today said it has extended its cash tender offer to purchase Orchid Cellmark to 5 p.m. EDT Oct. 7.

Pages

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.